EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study)

Shuyue Wang, Lixia Song, Rui Fan, Qianqian Chen, Ruisheng Fu, Mei You, Yuxiao Wu, Meng Cai, Yong Li, Meihong Xu iD

Advanced Science · 2025-09 · 12 (33)

DOI: 10.1002/advs.202417728 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Advanced Science, online erschienen am 28.05.2025. Verfasst von Shuyue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, 100191, China. Hauptthemen laut MEDLINE: Nucleotides, Aging, Dietary Supplements. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhen-ao Group Co., Ltd. (Dalian, China).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging impairs nutrient metabolism and accelerates biological aging, negatively affecting health and longevity. The Targeting Aging and Longevity with Exogenous Nucleotides (TALENTs) trial (ClinicalTrials.gov: NCT05243108) aimed to explore whether nucleotides (NTs) supplementation can delay biological aging and improve health outcomes in the elderly. The trial is a 19‐week, double‐blind, randomized, placebo‐controlled study in Chengdu, China, with 121 participants (60–70 years). Participants are randomly assigned to either NTs (1.2 g day −1 ) or placebo group (1:1). The results of primary outcomes showed that NTs had significantly greater reduction in median DNA methylation age compared to placebo over 19 weeks (β = −3.08 years, 95% CI: −5.07 to −1.10, P = 0.0023), with a trend toward reduction observed over 11 weeks (β = −1.94 years, 95% CI: −4.32 to 0.45, P = 0.11); whereas no significant difference changes of leukocyte telomere length are showed between groups (week 11: β = 0.09, 95% CI: −0.10 to 0.29, P = 0.36; week 19: β = 0.12, 95% CI: ‐0.05 to 0.28, P = 0.18). Insulin sensitivity improved in the NTs group, with a significant reduction in HOMA‐IR over 19 weeks (β = −0.45, 95% CI: −0.86 to −0.04, P = 0.033). No severe adverse events or significant changes in safety indicators are reported. Together, our findings establish that NTs may delay biological aging and improve insulin sensitivity with a well‐tolerated safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidesAgingDietary SupplementsHumansAgedMaleFemaleMiddle AgedDouble-Blind MethodDNA MethylationChina

Stichwörter der Autor:innen

DNA methylation ageanti‐aging interventionbody compositioninsulin sensitivitynucleotides supplementation

Substanzen

Nucleotides

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, 100191, China.
  • Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Peking University, Beijing, 100191, China.

ORCID-Profile: Meihong Xu

Förderung

  • Zhen-ao Group Co., Ltd. (Dalian, China)

Zitieren

APA

Wang, S., Song, L., Fan, R., Chen, Q., Fu, R., You, M., Wu, Y., Cai, M., Li, Y., & Xu, M. (2025). Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study). Advanced Science, 12(33). https://doi.org/10.1002/advs.202417728

Vancouver

Wang S, Song L, Fan R, Chen Q, Fu R, You M, et al. Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study). Advanced Science. 2025;12(33). doi:10.1002/advs.202417728

BibTeX
@article{Wang2025,
  author = {Wang, Shuyue and Song, Lixia and Fan, Rui and Chen, Qianqian and Fu, Ruisheng and You, Mei and Wu, Yuxiao and Cai, Meng and Li, Yong and Xu, Meihong},
  title = {Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study)},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {33},
  doi = {10.1002/advs.202417728}
}
Kostenlos starten →